Cidara Therapeutics, Inc. Profile Avatar - Palmy Investing

Cidara Therapeutics, Inc.

Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead …

Biotechnology
US, San Diego [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Cidara Therapeutics, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Cidara Therapeutics, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Cidara Therapeutics, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of CDTX's Analysis
CIK: 1610618 CUSIP: 171757107 ISIN: US1717571079 LEI: - UEI: -
Secondary Listings
CDTX has no secondary listings inside our databases.